Table 1.
Patient characteristics of 115 men with BCR and very low PSA concentration.
| Characteristic | Value |
|---|---|
| Age, yr | |
| Median (minimum–maximum) | 67.6 (48.4–85.7) |
| Mean ± SD | 66.9 ± 8.0 |
| PSA, ng/mL | |
| Median (minimum–maximum) | 0.13 (0.01–0.2) |
| Mean ± SD | 0.13 ± 0.06 |
| Category, ng/mL, % (n) | |
| ≤0.1 | 33.0% (38) |
| >0.1–0.15 | 32.2% (37) |
| >0.15–0.2 | 34.8% (40) |
| PSA doubling time, months | n = 83 |
| Median (minimum–maximum) | 4.9 (0.75–24) |
| Category, % (n) | |
| <3 | 23% (19) |
| 3–6 | 29% (24) |
| >6–12 | 29% (24) |
| >12 | 19% (16) |
| Gleason score, % (n) unless otherwise noted | n = 107 |
| Minimum–maximum | 6–10 |
| 6 | 8.4% (9) |
| 7a | 33.6% (36) |
| 7b | 24.3% (26) |
| 8 | 15.0% (16) |
| 9 | 15.9% (17) |
| 10 | 2.8% (3) |
| Additional treatment besides radical prostatectomy, % (n) | |
| Radiation therapy | 8.7% (10) |
| Androgen deprivation therapy | 8.7% (10) |
Percentages represent proportions of the overall study sample or the subgroup with available data regarding a variable, as applicable. Due to rounding, not all percentages may add up to exactly 100%. Abbreviations: PSA, prostate-specific antigen, and SD, standard deviation.